BRUKINSA
Drug timelines are a Plus or Pro feature.
49 regulatory and trial events tracked for BRUKINSA, covering 2019-11-14 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma [Phase 3]